NDI-091143

CAS No. 2375840-87-0

NDI-091143( —— )

Catalog No. M20771 CAS No. 2375840-87-0

NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 36 In Stock
5MG 55 In Stock
10MG 91 In Stock
25MG 186 In Stock
50MG 332 In Stock
100MG 355 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NDI-091143
  • Note
    Research use only, not for human use.
  • Brief Description
    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
  • Description
    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
  • In Vitro
    Thermal shift assays shows that NDI-091143 gives rise to considerable stabilization of both full-length ACLY and the N-terminal segment. The thermal shift data are consistent with limited proteolysis experiments using full-length ACLY, in which NDI-091143 together with Mg-ATP provided the greatest protection against digestion by chymotrypsin.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    ACLY
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    2375840-87-0
  • Formula Weight
    453.8
  • Molecular Formula
    C20H14ClF2NO5S?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:91 mg/mL (200.51 mM)
  • SMILES
    COC(=O)c1cc(Cl)c(O)c(S(=O)(=O)Nc2cc(-c3ccccc3)c(F)cc2F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jia Wei Silvana et al. An allosteric mechanism for potent inhibition of human ATP-citrate lyase[J]. Nature 2019.
molnova catalog
related products
  • Diazoxide

    Diazoxide is a potassium channel activator, which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions.

  • Fenbufen

    Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class.

  • Liriodendrin

    Liriodendrin regulates lung inflammation, the phosphorylation of the NF-kB (p65) and expression of vascular endothelial growth factor (VEGF).